Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center
Take the Jonsson Cancer Center Site Survey

Herceptin and Chemotherapy Treatment Combo Increases Survival Rates in Early Breast Cancer Patients

POSTED: October 20, 2011 Share

In this NBC Nightly News video, watch UCLA Jonsson Comprehensive Cancer Center researcher Dr. Dennis Slamon discuss a new study that reports that treating women with a combination of chemotherapy and the molecularly targeted drug Herceptin can significantly increase survival in patients with a specific genetic mutation that results in very aggressive disease.

 

Last updated: 3/2/2012 10:51:35 AM